OXFORD CENTRE FOR INNOVATION AND OXFORD INNOVATION ARE TALKING ABOUT US!
VITACCESS AND PHARNEXT LAUNCH INTERNATIONAL CMT&ME OBSERVATIONAL STUDY
HUGE GROWTH HELPS DIGITAL HEALTH START-UP LAND PLACE IN BUSINESS AWARDS FINAL
An Oxford-based digital health business has been identified as one of the region’s top three tech start-ups, having grown its workforce by 500 per cent in just 18 months.
WELCOME TO VITACCESS’ NEW WEBSITE
Digital health company Vitaccess and Pharnext SA, (FR0011191287 – ALPHA) a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic data and artificial intelligence, today announced the launch of an international study on Charcot-Marie-Tooth disease (CMT) using a bespoke digital app named CMT&Me.
Ground-breaking digital health company Vitaccess is proud and excited to launch its brand new website today. We’ve created a place for you to discover who we are, what we do and how we can help you.